HASBROUCK HEIGHTS, N.J., Feb. 5, 2014 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (Nasdaq:NYMX) is pleased to announce the appointment of Andre Monette as Chief Financial Officer of the Company. Mr. Monette, who is a Chartered Professional Accountant and Chartered Financial Analyst, brings to the company extensive experience and expertise in the financial and securities sectors as an executive in the securities industry and as a CFO of a public company. Mr. Monette served for seventeen years as Vice President of Finance and Administration for the North American subsidiary of Lombard Odier Group, a private Swiss bank based in Geneva. Prior to joining Nymox he provided corporate consulting services in financial reporting.
Dr. Paul Averback, CEO, said, "We are very pleased to have Andre joining Nymox management. His decades of international experience in financial matters involving Europe and the U.S. will be extremely valuable to the Company."
Dr. Averback said, "The Company thanks our departing CFO Roy Wolvin for his service to the Company and wishes him the best in his new endeavours."
This press release contains certain "forward-looking statements" as defined in the United States Private Securities Litigation Reform Act of 1995 that involve a number of risks and uncertainties. There can be no assurance that such statements will prove to be accurate and the actual results and future events could differ materially from management's current expectations. Such factors are detailed from time to time in Nymox's filings with the United States Securities and Exchange Commission and other regulatory authorities.
Brian Doyle Nymox Pharmaceutical Corporation 1-800-93NYMOX www.nymox.com